This episode covers Nicastro et al. (2025), who identify bi-allelic POPDC2 variants in four families causing a recessive cardiac syndrome marked by sinus-node dysfunction, atrioventricular conduction defects and, in some cases, hypertrophic cardiomyopathy. The study combines genetic sequencing, structural modeling, electrophysiology, tissue analyses and population biobank data to link impaired cAMP binding and loss of POPDC2 modulation of TREK-1 to the phenotype and to show heterozygous carriers are unlikely to be clinically affected.
0:00Welcome to Base by Base, the papercast that brings genomics to you, wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. So I want you to start off today by just imagining your heart's electrical system as this, um, perfectly timed orchestra.
0:16Well, that's a good way to look at it. Yeah. Right. Like in this scenario, the sinus node is the conductor, you know, setting the fundamental pace of the music. And then the atrioventricular node, or the AV node, is sort of the lead violinist.
0:29Catching the rhythm and seamlessly passing it to the rest of the symphony. Exactly. Making sure every single section plays in total harmony. And I mean, it's a delicate, continuous performance, right? It happens literally 1000000000s of times in an average lifespan.
0:441000000000s of times. wild to think about. Yeah, and those electrical impulses, they have to fire with just astonishing precision to keep blood pumping to the brain, to the body, everything. Right. But okay, what really happens when the conductor just suddenly loses the rhythm?
0:58Or, you know, when the electrical signal just completely stops. That is the terrifying question. Yeah. I want you to consider a real medical mystery here. We're talking about young, otherwise completely healthy individuals.
1:10Sometimes we're talking about young children or teenagers, right? Yeah, kids with their whole lives ahead of them. Exactly. And they suddenly develop these severe cardiac conduction defects. They're experiencing heart rates just dropping to dangerous levels, suddenly requiring emergency pacemakers.
1:26And you know, the scariest part is there's no obvious cause. Right, like no heart attacks, no aging related wear and tear, just a sudden catastrophic electrical failure out of nowhere. Today we celebrate the work of McKellen Nicastro, Najim Laruci, Connie Arbazina, and their extensive global consortium led by the Amsterdam UMC, University of Amsterdam, who have advanced our understanding of the genetic foundations of inherited cardiac conduction defects, and hypertrophic cardiomyopathy.
1:55So, when we hear about someone needing a pacemaker, I think we usually picture an older adult, right? Like the machinery of the heart has just naturally worn down over decades. Oh absolutely. Yeah, cardiac conduction defects, which we'll probably just call CCDs for short in this deep dive.
2:10They are primarily the consequence of that age related degeneration. Just normal wear and tear. Right. Or sometimes they result from, you know, structural heart disease or they present as a complication after major heart surgery.
2:23Okay, sure. But when a CCD suddenly appears in the young, that's completely different, isn't it? It is a massive red flag, a huge red flag for an underlying genetic disorder. Because, I mean, an 11 year old heart shouldn't just run out of battery.
2:37Exactly. We already know of a few gene variants that cause early onset CCD. But the frustrating reality in the clinic is that many of these young patients, they remain totally genetically unexplained. Wow, really?
2:50So doctors just don't know why it's happening. Right. I mean, we know the error is written somewhere in their DNA, obviously. But the genome is vast and the exact location of the mutation has just remained completely hidden.
3:01Okay, so to make this a bit more accessible for our listeners, think of this family of proteins we're looking at today. They're called the Popeye domain containing proteins, or POPDC for short. Let's think of them as the specialized electricians at the heart.
3:16The electricians, I like that. Right. And we already knew the job of one specific electrician, POPDC one. Like mutations there are associated with muscular dystrophy and AV block, where the signal from the top of the heart just fails to reach the bottom.
3:30Yes, the POPDC one link was well established. But there was another protein, POPDC 2, acting as this mysterious contractor just kind of working in the background. Yeah, and decades of research offered well, these really tantalizing clues about that specific contractor.
3:46Animal models, for instance. They strongly suggested POPDC 2 was absolutely vital for heart rhythm. What kind of animal models are we talking about here? Well, mice, for one. Mice missing the pop DC2 gene.
3:58They develop stress induced sinus pauses, and this dangerously slow heart rate, which we call brattycardia. Okay, so the heart just slows way down. Exactly. And then when scientists suppress the pop DC2 gene in zebrafish, the faith develops severe AV block.
4:12Wow, okay. Yeah, so the animal models were practically screaming that POPDC 2 was essential. Yet a direct link to a human disease for POPDC, too, was just entirely missing from the medical literature. But, I mean, the leap from a zebra fish or a mouse to a human patient is massive.
4:32The research team must have needed a starting point in the real world, right? Like a human case that proved those animal models were actually pointing in the right direction. They did. And that starting point emerged through a really intense clinical hunt, focusing on a child that the researchers refer to as part of family A.
4:48Okay, tell me about family. So this individual, somewhere between 11 and 15 years old, presented with just a terrifying clinical picture for a teenager, severe sinus no disease, AV block, and hypertrophic cardiomyopathy.
5:00Which is that's a dangerous thickening of the heart muscle, right? Yes, exactly. It makes it much harder for the heart to pump blood effectively. Wow. I mean, a teenager suddenly facing profound cardiac machinery failure like that.
5:12That is a nightmare for a family. And honestly, an incredibly complex puzzle for a cardiologist. Absolutely. And when the clinical team examined the family history, they noted something critical. The child's parents shared ancestry.
5:25They were actually 1st cousins. Oh, okay. So in genetics that immediately point suspicion toward an autosomal recessive trait, right? Spot on. We all inherit 2 copies of every gene, you know, one from each parent.
5:36When parents share ancestry, the statistical probability of both of them carrying the exact same rare hidden mutation is significantly higher. So to find that hidden mutation, the team essentially had to go in and read the entire instruction manual of this child's cellular machinery.
5:53Basically, yeah. They utilize whole XM sequencing. And just to clarify, instead of sequencing the entire genome, which, you know, includes a lot of non-coding space, Exome sequencing isolates just the one to 2% of the DNA that actually codes for proteins, right?
6:07Exactly. It's much more targeted approach. And hidden within that data. They finally found it. A rare homozygous variant in the POPDC 2 gene. Homozygous, meaning the child had 2 bad copies. Right. Both parents were heterozygous carriers, meaning they each possessed one normal copy and one mutated copy, and they were completely healthy.
6:28But the child tragically inherited the mutated copy from both of them. Yes. But, you know, a single family presentation is a tragic anecdote, but it isn't enough to establish a brand new genetic syndrome in the medical textbook.
6:40Oh for sure. You can't base a whole new disease profile on one patient. The team needed more evidence. Which is where expanding the search comes in. And this is where modern genomic medicine becomes a truly global detective story.
6:52I love this part. How did they widen the net? Well, they screened 78 other individuals who had similar completely unexplained clinical presentations of conduction disease and hypertrophic cardiomyopathy?
7:04Okay. But they also tapped into massive global genetic databases, specifically decipher and gene matcher. Right, gene matcher. You can think of these as like secure matchmaking networks for medical researchers, right?
7:16That's a perfect way to describe it. A clinician in one country. Uploads an anonymous genetic profile of a mysterious disease, hoping a scientist halfway across the world has a patient with the exact same genetic typo.
7:29And did this global dragnet actually work? It did. It really did. It led them to 3 more families with similar clinical profiles. And crucially, all of them carried rare variants in both copies of their POPDC2 genes.
7:44Wow. Okay, so finding the genetic typo is a major breakthrough clearly. But we really have to push this further for this deep dive, because simply proving the spelling error exists doesn't explain how the machinery actually breaks down inside the heart cell.
7:57You're exactly right. And the team actually hit a significant wall at this exact stage of the research. Really? What was the roadblock? Well, to see how these specific mutations broke the POPDC 2 protein.
8:08They needed to examine its physical three-dimensional shape. But the problem was that no experimental 3D structure of the human POPDC 2 protein existed in any scientific database anywhere. Wait, really?
8:21Not at all. So without a physical blueprint, they basically had to construct one digitally from scratch. Yes, from the ground up. They turn to revolutionary artificial intelligence for this, specifically Alpha Fold 2 Multimer, alongside a structural modeling tool called Swiss model.
8:37Oh, alpha fold, that's huge right now. So alpha fold predicts how a linear string of amino acids folds into a complex three-dimensional shape. Right. And because POPDC 2 functions by binding to another POPDC 2 molecule.
8:52They needed the multimmersion of the AI to build the full Demeric structure. Got it. So it's modeling how the pieces fit together. Exactly. They then merge that with Swiss model to predict exactly how this newly modeled protein, binds to a crucial cellular messenger called cyclic AMP, or cam MP.
9:09Okay let's bring in another analogy here. Think of cam P as the adrenaline signal, you know, the emergency flare of the cell. Normally, PUPDC 2 catches that flare in a specific pocket and tells the surrounding potassium channels to open the floodgates for an electrical signal.
9:23Yes, it's a signaling cascade. But when they mapped the patient's mutations onto this new 3D model, What happened? They found that the variants literally crushed the catchment on the POPDC 2 protein, right?
9:36Crushed it completely. The structural models showed the binding pocket was ruined, so the emergency flare goes entirely unnoticed, the channels stay shut, and the heart's electrical system stalls. That is just incredible that they could see that virtually.
9:49It is, but you know, that structural destruction had to be proven in a functional biological environment too. A computer model isn't enough on its own. So what was the next step? The team moved to patch clamp electrophysiology.
10:01They utilize human embryonic kidney cells, known as HEK 293 cells. Okay, hold on. I have to challenge the step. A kidney cell in a plastic dish doesn't beat. It isn't part of a heart. How does testing a kidney cell prove anything about a cardiac arrhythmia?
10:17It's a really fair question, but HEK 293 cells. They're essentially biological blank slates. Oh, I see Yeah, they allow researchers to test specific electrical properties without interference from the 1000s of other specialized proteins found in a real heart cell.
10:33It isolates the variable. That makes sense. Okay. So the researchers engineered these kidney cells to express either the healthy POPDC 2 protein or the mutated versions found in the patients. Then, they measured how POPDC 2 interacted with a specific potassium channel called TRK1.
10:51And potassium channels just to remind everyone, those are the microscopic pores that let electrical current flow across the cell membrane, creating the actual spark that makes a heartbeat possible. Precisely.
11:02So they are measuring those microscopic electrical sparks in total isolation. So to solve this, they didn't just sequence a gene. They digitally built the protein from scratch, ran it in a kidney cell to isolate it, and measured the tiny electrical currents.
11:16Yeah, using a tiny glass pipe pet sealed to the cell membrane. And they prove that normal people PDC 2 binds with the TRK1 potassium channel and significantly boosts the electrical current flowing through it.
11:25It basically acts as an amplifier. But what about when they tested the mutated POPDC 2 proteins from the patients? complete functional failure. Wow. The mutant proteins failed entirely to increase the TRK1 current.
11:39They were so utterly useless. They generated the exact same electoral current as a cell with an empty vector. Meaning a cell with no POPDC 2 inserted in it at all. Exactly. The mutated protein was functionally invisible.
11:54Okay, so we have a broken catchment. And we have proof the electrical current is choked off in a single cell, but we still have to translate this back to the macroscopic scale of a human patient, right?
12:03Yes, and to bridge that gap, they built highly complex computer simulations of human sinus node and atrial cells. Because you can't just extrapolate a single cells current to a whole beating heart. Exactly.
12:15They took the altered electrical data from the isolated patch of clamp experiments and fed it into this virtual human heart model. And what did the simulation show? I'm guessing it extended the resting phase between beats, like the diastolic depolarization rate.
12:28You nailed it. In human terms, the heart takes way too long to recharge before it can fire the nose beat, and that is what creates those dangerous pauses. So the virtual model confirmed the clinical reality we saw on the patients.
12:42It did, and that clinical reality across the 4 families representing six affected individuals was remarkably consistent and severe. Let's run down those numbers because they are striking. They really are.
12:53So all 6 individuals had AV block. 4 of them had sinus node disease, presenting as those dangerous pauses or severe Bradycardia. 2 experienced sudden cardiac arrest, and 2 had hypertrophic cardiomyopathy.
13:08And how many needed intervention? Five out of the 6 required pacemakers, with 2 needing implantable cardiovertor defibrillators or ICDs to physically shock the heart if it went into a fatal rhythm. This brings up a critical discrepancy, though.
13:22We discussed earlier that mutations in the related protein POPDC one cause AV block, but those patients also typically develop muscular dystrophy. But these individuals with POPDC 2 mutations, they showed no overt clinical signs of a muscle wasting disease, did they?
13:38This is an isolated primary cardiac syndrome. Yes, purely cardiac. In fact, one patient even underwent a muscle biopsy. And while there were some, you know, very minor microscopic abnormalities. There was absolutely no overt muscular dystrophy.
13:53So why the difference? If POPDC one and Pico PDC 2 are such similar electricians in the body, why do mutations in POPDC 2 cause sinus snow disease, while POPDC one mutations do not? This is where the researchers deployed human heart transcript comics to map the cellular anatomy.
14:11Which is just incredible technology. Oh, it's amazing. Using single nucleus RNA frequencing and spatial transcript comics, which basically creates a highly detailed molecular map of exactly where genes are turned on and the heart tissue.
14:22They found the answer. And what did the map show? Well, it showed that POPDC one and POPDC 2 are highly co-expressed in the AV node. They work together there as a complex. If either one is broken, the entire complex fails, resulting in AV block.
14:34That explains the AV block in both mutations, but the molecular map of the sinus node looks completely different, doesn't it? Entirely different. In the sinus node, which is the primary conductor of our hearts orchestra, POPDC 2 is incredibly abundant, while POPDC1 expression is remarkably sparse.
14:52Ah, so the sinus node relies almost entirely on POPDC 2 to function. Yes. So if you mutate POPDC one, the sinus note is mostly fine because it wasn't relying on it anyway. Yeah. But if you mutate BOBDC too, The sinus node loses its primary regulatory protein entirely, leading directly to the sinus pauses and Brady cardio scene in these patients.
15:13Wow, so the spatial mapping just perfectly predicts the clinical disease. The final step in this detective story, though, is proving beyond a shadow of a doubt that you absolutely need 2 bad copies of this gene to get sick.
15:23The parents of family A were perfectly healthy, but how do we know that holds true across the general public? The team went huge for this. They cross-reference their findings against massive population biobanks, specifically the UK biobank and decode in Iceland.
15:37Those databases are enormous. Huge. They contain genetic and medical data representing over 1000000 individuals. And searching through that immense data set, they found 426 heterozygous carriers. So 426 people walking around with just one mutated copy of POPDC 2.
15:54And when they looked at the medical records of those 426 carriers, what did the cardiac health data actually show? Zero association with the clinical syndrome? There were no statistically significant instances of AB block, cardiac arrest, unexplained pacemakers or hypertrophic cardiopathy?
16:12Not at all. None. This 1000000 person proof confirms this is strictly an autosomal recessive condition? If you possess just one healthy copy of the POPDC2 gene, that single copy is robust enough to keep the entire electrical orchestra playing perfectly.
16:27I mean, just consider the immediate relief that provides to these families. If a teenager is diagnosed with this condition, their siblings can be tested. And if a sibling finds out they are only a heterozygous carrier.
16:38They are freed from a lifetime of intense clinical anxiety. They don't need constant monitoring for a sudden cardiac arrest. They can just live their lives. Right. And for the patients themselves, this research changes clinical practice tomorrow, doesn't it?
16:50It absolutely does. POPDC 2 must now be officially added to clinical genetic testing panels. When a young person presents with unexplained sinus node dysfunction, AV block or hypertrophic cardiomyopathy.
17:04Cardiologists now know exactly which genetic sequence to check. It replaces the terror of an unexplained diagnosis with a precise targeted answer. It gives them a concrete reason for why this is happening.
17:15Yeah, but, you know, we have definitely found the broken switch in the genetic code, but I want to push back on the idea that every single mystery here is solved. The paper acknowledges limitations. We are still reverse engineering exactly how that broken switch short circuits the entire electrical grid in a living, breathing human.
17:33That's a very fair point. The exact cellular mechanism of why a reduced tirade came one current causes Bradycardia remains mathematically complex. Right, because computer models aren't perfect. Exactly.
17:45When they fed the patch clamp data into their computer simulation, they simulated a 41% reduction in Tierra K1 current to achieve that altered diastolic depolarization rate. But translating a 41% reduction in a simulation to the profound, life-threatening sinus pauses seen in human patients.
18:05I mean, that highlights that biological systems have compensatory mechanisms that computer models just still struggle to fully capture. Yeah, the human body is incredibly adapted trying to fix itself. And sometimes the mass just gets fuzzy.
18:18And there was also a massive curveball with one of the patients in family D, wasn't there? Yes, there was. They presented with severe bradycardia and cardiac arrest, but it happened during an episode of acute fulminant myocarditis.
18:29Which is this explosive, severe inflammation of the heart muscle, right? Like from a virus. Right. So the question becomes, was the viral inflammation, the spark that ignited the genetic powder keg, or was the myocarditis itself a direct feature of the POPDC 2 disease?
18:44How do they answer that? Well, the authors are very transparent, that they cannot entirely rule out the role of the myocarditis as a trigger in this specific case. However, given that this patient's electrical phenotype perfectly matched the other 5 individuals, and they had 2 highly destructive truncating mutations.
19:02The genetic defect was highly likely the primary culprit. It makes sense, but it definitely points to a critical next step for the scientific community. Absolutely. We need long-term clinical follow-up of these families and even the headers, I guess carriers, over decades, we really need to understand every nuance of how this genetic vulnerability interacts with environmental stress tests, like severe viral infections.
19:26Right, because life happens, people get sick, and we need to know how this specific mutation reacts. Exactly. Well, as we wrap up this deep dive. Let's just distill all of these complex layers we've talked about.
19:36The AI, protein modeling, the transcriptomics, the global databases, down to the core takeaway. What is the central bottom line insight you think our listeners should take away from this paper? The central insight is that biologic loss of function variants in the POPDC 2 gene, cause a newly identified recessive cardiovascular syndrome, characterized by severe electrical convection defects and hypertrophic cardiomyopathy.
20:00By destroying the protein's ability to bind KMP and regulate TRK1 potassium channels, these variants short circuit the heart's intrinsic pacemaker system. What does this mean for the future of diagnosing and treating rare electrical hard disorders in the young?
20:14I think it means the era of treating the symptoms while guessing at the underlying cause is rapidly ending. And honestly, it leaves me with one final provocative thought. How many other idiopathic or totally unexplained diseases are out there right now, just waiting for this level of multi-layered science to decode them?
20:33We are talking about taking single cell spatial transcript comics, AI protein folding that solved a 50 year grand challenge in biology, and 1000000 person biobanks, and aiming all of those incredible tools at a single medical mystery.
20:46If the diagnostic tools of the past were like looking through a blurry window, this paper proves we are now building microscopes that can see the very code of life down to the exact shape of a single binding pocket.
20:56It is truly a new frontier in medicine. It really is. This episode was based on an open access article under the CCBY4.0 license. You can find a direct link to the paper and the license in our episode description.
21:09If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating. If you'd like to support our work, use the donation link in the description. Now stay with us for an original track created especially for this episode and inspired by the article you've just heard about.
21:24Thanks for listening and join us next time as we explore more science base by base.
